For example, CSF chitinases have emerged as markers of neuroinflammation in patients with ALS with higher CSF CHIT1, CHI3L1 and CHI3L2 associating with faster disease progression, greater cognitive dysfunction and/or shorter survival [143–147]. Here, CHI3L2 is linked to amyotrophic lateral sclerosis.